Can Utepreva’s new device solve the biggest problem in endometrial cancer diagnosis?
Utepreva’s FDA-cleared endometrial sampler promises earlier cancer detection. Find out how this device could reshape diagnostics today.
Is culture-free pneumonia testing finally viable as Pattern Bioscience nears regulatory submission
Pattern Bioscience advances rapid pneumonia diagnostics toward FDA clearance. Discover what this means for ICU care and antibiotic resistance.
Why BlueWind Medical’s latest FDA clearance matters for long-term urgency urinary incontinence care
BlueWind Medical secures FDA clearance for an enhanced Revi wearable. Find out why usability may define the next phase of neuromodulation adoption.